Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tobacco-Related Carcinoma clinical trials
Every US clinical trial registered for Tobacco-Related Carcinoma — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
11 US clinical trials · 8 currently recruiting
The research picture
Tobacco-Related Carcinoma has 11 registered US clinical trials, 8 of them open to new participants right now — about 73% of the total.
- 8
- recruiting participants now
- 73%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 6
- top sponsor: Ohio State University Comprehensive Cancer Center
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication
Ohio State University Comprehensive Cancer Center
NCT07346092
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Ronald Myers
NCT05679349
Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities
University of California, San Francis
NCT07049757
A Smoke-Free Home Intervention in Tribal Communities
Emory University
NCT06583148
Manipulating E-Cigarette Nicotine to Promote Public Health
Ohio State University Comprehensive Cancer Center
NCT06448351
Informing Oral Nicotine Pouch Regulations to Promote Public Health
Ohio State University Comprehensive Cancer Center
NCT06315881
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
AIDS Malignancy Consortium
NCT04949464
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
Ohio State University Comprehensive Cancer Center
NCT06249984
Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
OHSU Knight Cancer Institute
NCT04969978
Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities
Ohio State University Comprehensive Cancer Center
NCT04340531
Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
Ohio State University Comprehensive Cancer Center
NCT06644664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Tobacco-Related Carcinoma Trial Landscape
ClinicalTrials.gov lists 11 US studies indexed under Tobacco-Related Carcinoma, and 8 of those are currently open to recruitment — roughly 73% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Tobacco-Related Carcinoma shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Tobacco-Related Carcinoma is led by Ohio State University Comprehensive Cancer Center with 6 indexed trials, alongside 5 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Tobacco-Related Carcinoma?
PlainTrial tracks 11 US clinical trials for Tobacco-Related Carcinoma, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Tobacco-Related Carcinoma?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.